CA15-3, Human (Cancer Antigen 15-3) BioAssay ELISA Kit

£804.00 96 Tests

Breast cancer is the most common life-threatening malignant lesion in women of many developed countries today, with approximately 180,000 new cases diagnosed every year. Roughly half of these newly diagnosed patients are node-negative, however 30% of these cases progress to metastatic disease. There are a number of tumor markers that can help clinicians to identify and diagnose which breast cancer patients will have aggressive disease and which will have an indolent course. These markers include estrogen and progesterone receptors, DNA ploidy and percent-S phase profile, epidermal growth factor receptor, HER-2/neu oncogene, p53 tumor suppressor gene, cathepsin D, proliferation markers and CA15-3. CA15-3 is most useful for monitoring patients post-operatively for recurrence, particularly metastatic diseases. 96% of patients with local and systemic recurrence have elevated CA15-3, which can be used to predict recurrence earlier than radiological and clinical criteria. A 25% increase in the serum CA15-3 is associated with progression of carcinoma. A 50% decrease in serum CA15-3 is associated with response to treatment. CA15-3 is more sensitive than CEA in early detection of breast cancer recurrence. In combination with CA125, CA15-3 has been shown to be useful in early detection of relapse of ovarian cancer. CA15-3 levels are also increased in colon, lung and hepatic tumors.

The CA15-3, Human (Cancer Antigen 15-3) BioAssay? ELISA Kit is for the quantitative determination of the Cancer Antigen CA15-3 concentration in human serum.

Test Principle:
The CA15-3 ELISA test is based on the principle of a solid phase enzyme-linked immunosorbent assay. The assay system utilizes a monoclonal antibody directed against a distinct antigenic determinant on the intact CA15-3 molecule is used for solid phase immobilization (on the microtiter wells). A rabbit anti-CA15-3 antibody conjugated to horseradish peroxidase (HRP) is in the antibody-enzyme conjugate solution. The test sample is allowed to react sequentially with the two antibodies, resulting in the CA15-3 molecules being sandwiched between the solid phase and enzymelinked antibodies. After two separate 1-hour incubation steps at 37?C, the wells are washed with Wash Buffer to remove unbound labeled antibodies. A solution of TMB Reagent is added and incubated for 20 minutes, resulting in the development of a blue colour. The color development is stopped with the addition of Stop Solution changing the color to yellow. The concentration of CA15-3 is directly proportional to the colour intensity of the test sample. Absorbance is measured spectrophotometrically at 450nm.

SKU: USC0050-24H Categories: ,

Additional information

Kit Components

C0050-24H1: Microtiter Strips, 1×96 wells. Murine Monoclonal Anti-CA15-3 coated
C0050-24H2: Standard , 0unit/ml, 1x1vial
C0050-24H3: Standard, 15unit/ml, 1x1vial
C0050-24H4: Standard, 30unit/ml, 1x1vial
C0050-24H5: Standard, 60unit/ml, 1x1vial
C0050-24H6: Standard, 120unit/ml, 1x1vial
C0050-24H7: Standard, 240unit/ml, 1x1vial
C0050-24H8: Wash Buffer Concentrate, 20X, 1x50ml
C0050-24H9: Sample Diluent, 1x100ml
C0050-24H10: Enzyme Conjugate Concentrate, 22X, 1x1ml
C0050-24H11: Enzyme Conjugate Diluent, 1x21ml
C0050-24H12: TMB Reagent, 1x11ml
C0050-24H13: Stop Solution (1N HCl), 1x11ml

Storage and Stability

Store all components at 4°C. Stable for 6 months after receipt. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

Shipping Temperature

On Dry Ice

Shelf Life

6 Months